Epidemiology of Legionnaires' Disease in Italy, 2004-2019: A Summary of Available Evidence.

Matteo Riccò, Simona Peruzzi, Silvia Ranzieri, Pasquale Gianluca Giuri
Author Information
  1. Matteo Riccò: Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL), AUSL-IRCCS di Reggio Emilia, Via Amendola n.2, I-42022 Reggio Emilia, Italy. ORCID
  2. Simona Peruzzi: Laboratorio Analisi Chimico Cliniche e Microbiologiche, Ospedale Civile di Guastalla, AUSL-IRCCS di Reggio Emilia, I-42016 Guastalla, Italy.
  3. Silvia Ranzieri: Department of Medicine and Surgery, School of Occupational Medicine, University of Parma, Via Gramsci n.14, I-43123 Parma, Italy. ORCID
  4. Pasquale Gianluca Giuri: Dipartimento Internistico Interaziendale, Struttura Operativa Semplice Dipartimentale "Medicina Infettivologica", AUSL-IRCCS di Reggio Emilia, Ospedale "Sant'Anna", I-42035 Castelnovo ne' Monti, Italy. ORCID

Abstract

Legionnaires' disease (LD) incidence has been increasing in several European countries since 2011. Currently, Italy is experiencing high notification rates for LD, whose cause still remains scarcely understood. We sought to summarize the available evidence on the epidemiology of LD in Italy (2004-2019), characterizing the risk of LD by region, sex, age group, and settings of the case (i.e., community, healthcare, or travel-associated cases). Environmental factors (e.g., average air temperatures and relative humidity) were also included in a Poisson regression model in order to assess their potential role on the annual incidence of new LD cases. National surveillance data included a total of 23,554 LD cases occurring between 2004 and 2019 (70.4% of them were of male gender, 94.1% were aged 40 years and older), with age-adjusted incidence rates increasing from 1.053 cases per 100,000 in 2004 to 4.559 per 100,000 in 2019. The majority of incident cases came from northern Italy (43.2% from northwestern Italy, 25.6% from northeastern Italy). Of these, 5.9% were healthcare-related, and 21.1% were travel-associated. A case-fatality ratio of 5.2% was calculated for the whole of the assessed timeframe, with a pooled estimate for mortality of 0.122 events per 100,000 population per year. Poisson regression analysis was associated with conflicting results, as any increase in average air temperature resulted in reduced risk for LD cases (Incidence Rate Ratio [IRR] 0.807, 95% Confidence Interval [95% CI] 0.744-0.874), while higher annual income in older individuals was associated with an increased IRR (1.238, 95% CI 1.134-1.351). The relative differences in incidence between Italian regions could not be explained by demographic factors (i.e., age and sex distribution of the population), and also a critical reappraisal of environmental factors failed to substantiate both the varying incidence across the country and the decennial trend we were able to identify.

Keywords

References

  1. Int J Occup Med Environ Health. 2018 Jan 15;31(3):317-331 [PMID: 29165429]
  2. Am J Infect Control. 2010 Sep;38(7):540-5 [PMID: 20472324]
  3. Euro Surveill. 2019 May;24(20): [PMID: 31115313]
  4. Appl Environ Microbiol. 2019 Oct 30;85(22): [PMID: 31519664]
  5. Cien Saude Colet. 2019 Mar;24(3):793-804 [PMID: 30892501]
  6. Euro Surveill. 2020 May;25(20): [PMID: 32458793]
  7. Emerg Infect Dis. 2017 Nov;23(11):1843-1851 [PMID: 29048279]
  8. Environ Int. 2019 Dec;133(Pt A):105176 [PMID: 31654985]
  9. Infect Dis Clin North Am. 2017 Mar;31(1):7-27 [PMID: 28159177]
  10. Arch Public Health. 2020 Oct 7;78:92 [PMID: 33042538]
  11. Environ Res. 2017 Jan;152:485-495 [PMID: 27717486]
  12. Infect Dis Clin North Am. 2017 Mar;31(1):123-135 [PMID: 28159172]
  13. PLoS One. 2020 Nov 25;15(11):e0241724 [PMID: 33237924]
  14. Environ Res. 2019 Nov;178:108721 [PMID: 31541805]
  15. Curr Environ Health Rep. 2018 Jun;5(2):263-271 [PMID: 29744757]
  16. Chest. 2005 Sep;128(3):1401-5 [PMID: 16162735]
  17. Environ Res. 2018 Oct;166:55-60 [PMID: 29864633]
  18. Lancet. 2016 Jan 23;387(10016):376-385 [PMID: 26231463]
  19. Infect Genet Evol. 2016 Sep;43:108-22 [PMID: 27180896]
  20. Infection. 2021 Apr;49(2):321-325 [PMID: 33315182]
  21. Euro Surveill. 2018 Dec;23(50): [PMID: 30563592]
  22. Emerg Infect Dis. 2014 Nov;20(11):1795-1802 [PMID: 25513657]
  23. Epidemiol Infect. 2016 Dec;144(16):3483-3493 [PMID: 27572105]
  24. Public Health Rep. 2015 May-Jun;130(3):222-9 [PMID: 25931626]
  25. Curr Issues Mol Biol. 2021;42:81-96 [PMID: 33284133]
  26. Int J Environ Res Public Health. 2020 Oct 08;17(19): [PMID: 33050023]
  27. Infect Dis Clin North Am. 2017 Mar;31(1):167-178 [PMID: 27979684]
  28. Acta Biomed. 2021 Sep 02;92(4):e2021324 [PMID: 34487097]
  29. BMC Public Health. 2019 Dec 3;19(1):1624 [PMID: 31795996]
  30. Euro Surveill. 2017 Jul 6;22(27): [PMID: 28703097]
  31. Trop Med Infect Dis. 2021 Apr 24;6(2): [PMID: 33923347]
  32. Ind Health. 2020 Apr 2;58(2):182-192 [PMID: 31548469]
  33. Occup Environ Med. 2014 Oct;71(10):713-6 [PMID: 25080542]
  34. J Travel Med. 2015 Sep-Oct;22(5):325-37 [PMID: 26220258]
  35. Trends Microbiol. 2021 Sep;29(9):860-861 [PMID: 33994277]
  36. N Engl J Med. 1977 Dec 1;297(22):1189-97 [PMID: 335244]
  37. PLoS Pathog. 2009 Jul;5(7):e1000508 [PMID: 19593377]
  38. Sci Rep. 2020 Apr 30;10(1):7337 [PMID: 32355282]
  39. Int J Environ Res Public Health. 2019 Feb 25;16(4): [PMID: 30823571]
  40. Infect Dis Clin North Am. 2017 Mar;31(1):137-153 [PMID: 28159173]
  41. Int J Hyg Environ Health. 2006 Nov;209(6):547-52 [PMID: 16815095]
  42. Ann Ig. 2019 Sep-Oct;31(5):474-481 [PMID: 31304527]
  43. Epidemiol Infect. 2015 Aug;143(11):2416-25 [PMID: 25427871]
  44. Euro Surveill. 2013 Jun 06;18(23): [PMID: 23787129]
  45. Euro Surveill. 2021 Feb;26(7): [PMID: 33602385]
  46. Int J Environ Res Public Health. 2020 Apr 28;17(9): [PMID: 32353925]
  47. PLoS One. 2019 Jul 9;14(7):e0218687 [PMID: 31287819]
  48. Euro Surveill. 2021 Jun;26(25): [PMID: 34169817]
  49. Annu Rev Pathol. 2020 Jan 24;15:439-466 [PMID: 31657966]
  50. Euro Surveill. 2021 Jun;26(25): [PMID: 34169820]
  51. Curr Opin Infect Dis. 2018 Aug;31(4):325-333 [PMID: 29794542]
  52. Epidemiol Infect. 2020 Jun 29;148:e156 [PMID: 32594925]
  53. Med Mal Infect. 2015 Mar;45(3):65-71 [PMID: 25722040]

Word Cloud

Created with Highcharts 10.0.0LDItalycasesincidenceperefactors11000000Legionnaires'diseaseincreasingratesepidemiologyrisksexageitravel-associatedaverageairrelativealsoincludedPoissonregressionannual200420191%older2%5populationassociated95%severalEuropeancountriessince2011Currentlyexperiencinghighnotificationwhosecausestillremainsscarcelyunderstoodsoughtsummarizeavailableevidence2004-2019characterizingregiongroupsettingscasecommunityhealthcareEnvironmentalgtemperatureshumiditymodelorderassesspotentialrolenewNationalsurveillancedatatotal23554occurring704%malegender94aged40yearsage-adjusted0534559majorityincidentcamenorthern43northwestern256%northeastern9%healthcare-related21case-fatalityratiocalculatedwholeassessedtimeframepooledestimatemortality122eventsyearanalysisconflictingresultsincreasetemperatureresultedreducedIncidenceRateRatio[IRR]807ConfidenceInterval[95%CI]744-0874higherincomeindividualsincreasedIRR238CI134-1351differencesItalianregionsexplaineddemographicdistributioncriticalreappraisalenvironmentalfailedsubstantiatevaryingacrosscountrydecennialtrendableidentifyEpidemiologyDisease2004-2019:SummaryAvailableEvidenceLegionellapneumophilatypingLegionnaires’cultivationdiagnosis

Similar Articles

Cited By (8)